Protect Pharmaceutical Corporation
PRTT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.04 | 0.02 | 0.00 |
| FCF Yield | 31.33% | 0.00% | -871.76% | -288.43% |
| EV / EBITDA | 0.32 | 2.83 | 0.37 | -0.18 |
| Quality | ||||
| ROIC | 16.74% | 16.39% | 9.65% | 9.27% |
| Gross Margin | 54.86% | 53.84% | 50.83% | 56.31% |
| Cash Conversion Ratio | 0.23 | 0.09 | -2.99 | 0.52 |
| Growth | ||||
| Revenue 3-Year CAGR | 17.37% | 20.00% | 139.68% | – |
| Free Cash Flow Growth | 0.00% | 100.00% | -6.35% | -398.23% |
| Safety | ||||
| Net Debt / EBITDA | -0.24 | -0.30 | 0.06 | -0.99 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.50 | 0.76 | 0.48 | 0.67 |
| Cash Conversion Cycle | 881.41 | 631.04 | 940.74 | 653.06 |